Royal Bank Of Canada Rani Therapeutics Holdings, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.85 - $3.67 $57 - $113	-31 Reduced 72.09%	12 $0
Q3 2023 Nov 14, 2023	SELL	$2.17 - $4.44 $95 - $195	-44 Reduced 50.57%	43 $0
Q4 2022 Feb 14, 2023	SELL	$5.51 - $10.02 $11 - $20	-2 Reduced 2.25%	87 $0
Q3 2022 Nov 14, 2022	BUY	$8.23 - $12.4 $510 - $768	62 Added 229.63%	89 $1,000
Q1 2022 May 16, 2022	BUY	$12.21 - $23.14 $329 - $624	27 New	27 $0

5.77M

2.5K

2.2K

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $35.8M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.